Fingerprint
Dive into the research topics where Christopher P Mill is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
BET inhibitor-based combinations targeting novel dependencies in MECOM-rearranged (r) AML
Birdwell, C. E., Fiskus, W., Mill, C. P., Kadia, T. M., Daver, N., DiNardo, C. D., Sasaki, K., Davis, J. A., Das, K., Hou, H., Jain, A., Malovannaya, A., Flores, L. B., Pourebrahim, R., Yuan, S., Su, X., Ceribelli, M. & Bhalla, K. N., Feb 2026, In: Leukemia. 40, 2, p. 304-313 10 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations -
Correction: BET inhibitor-based combinations targeting novel dependencies in MECOM-rearranged (r) AML (Leukemia, (2026), 40, 2, (304-313), 10.1038/s41375-025-02842-w)
Birdwell, C. E., Fiskus, W., Mill, C. P., Kadia, T. M., Daver, N., DiNardo, C. D., Sasaki, K., Davis, J. A., Das, K., Hou, H., Jain, A., Malovannaya, A., Flores, L. B., Pourebrahim, R., Yuan, S., Su, X., Ceribelli, M. & Bhalla, K. N., Apr 2026, In: Leukemia. 40, 4, p. 856 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Highly effective combination of BRG1/BRM inhibitor with BET inhibitor or decitabine for high-risk MECOM-rearranged AML
Fiskus, W., Mill, C. P., Piel, J., Collins, M., Hentemann, M., Cuglievan, B., Birdwell, C. E., Das, K., Davis, J. A., Hou, H., Jain, A., Malovannaya, A., Flores, L. B., Kadia, T. M., Daver, N., Sasaki, K., Takahashi, K., Hammond, D., Wang, J. & Loghavi, S. & 4 others, , Jan 2026, In: HemaSphere. 10, 1, e70289.Research output: Contribution to journal › Article › peer-review
Open Access -
Overcoming menin inhibitor resistance in AML cells with combinations including BET proteins and a dual BRG1/BRM inhibitor
Fiskus, W., Mill, C. P., Issa, G. C., Piel, J., Collins, M., Hentemann, M., Cuglievan, B., Hou, H., Jain, A., Malovannaya, A., Kadia, T. M., Daver, N., Sasaki, K., Takahashi, K., Hammond, D., Senapati, J., Loghavi, S., Flores, L. B., Su, X. & DiNardo, C. D. & 1 others, , 2026, (Accepted/In press) In: Blood.Research output: Contribution to journal › Article › peer-review
-
Correction to: Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1 (Blood Cancer Journal, (2023), 13, 1, (53), 10.1038/s41408-023-00826-6)
Fiskus, W., Mill, C. P., Birdwell, C., Davis, J. A., Das, K., Boettcher, S., Kadia, T. M., DiNardo, C. D., Takahashi, K., Loghavi, S., Soth, M. J., Heffernan, T., McGeehan, G. M., Ruan, X., Su, X., Vakoc, C. R., Daver, N. & Bhalla, K. N., Dec 2025, In: Blood cancer journal. 15, 1, 99.Research output: Contribution to journal › Comment/debate › peer-review
Open Access